Výsledky vyhledávání - "Ola M, Elfarargy"

Down-regulated MiRNA 29-b as a diagonistic marker in colorectal cancer and its correlation with ETV4 and Cyclin D1 immunohistochemical expression

Autor: Hala Mosaad, Mona Mostafa Ahmed, Mostafa M. Elaidy, Ola M. Elfarargy, Mai Mohamed Abdelwahab, Hanim M. Abdelnour

Publikováno v: Cancer Biomarkers. :1-11

BACKGROUND: Colorectal cancer (CRC) is the most common malignant tumor of the gastrointestinal tract with unfavorable prognosis. Therefore, novel biomarkers that may be used for new diagnostic strategies and drug-targeting therapy should be developed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8b44e9cd24f144a093d032f3d4c2150
https://doi.org/10.3233/cbm-220349

Zobrazit plný text záznamu

Prognostic impact of immunohistochemical expression of claudin-4 and epithelial mesenchymal-related markers (Snail-1) in breast invasive duct carcinoma

Autor: Ola M. Elfarargy, MennatAllah H. Fikry, Nashwa Nawar, Hayam E. Rashed, Ahmed A Alnagar, Heba M. Abdelgeleel, Ihab Matar, Nelly Mohamed Said, Mohamed I. Abdelhamid

Publikováno v: Revista de Senología y Patología Mamaria. 35:23-32

Introduction Although the molecular profile of the breast provides prognostic indicators, risk stratification in breast cancer continues to be a challenge. Therefore, it is mandatory to seek new prognostic markers that could aid the early diagnosis o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b98545810564b992ad366306e59a485
https://doi.org/10.1016/j.senol.2020.10.003

Zobrazit plný text záznamu

Association of CCND1 (c.723G A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study

Autor: Mohamed Adel, El-Eshmawy, Hanaa Elsayed, Shahin, Nanis S, El-Beltagy, Dina, Abdel Hamid, Ola M, Elfarargy, Dalia Hamouda, Elsayed, Afaf M, Elsaid, Rami M, Elshazli, Noura M, Mohamed

Publikováno v: Molecular biology reports.

The prevalence rate of breast carcinoma (BC) among multiple ethnic populations required more explanations to understand the pathogenesis mechanisms for the development of this type of cancer. The principal purpose of this work is to validate the corr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::04658cae2c1f5252d0a05bfd6c28603d
https://pubmed.ncbi.nlm.nih.gov/36534235

Zobrazit plný text záznamu

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Autor: Reham A. Salem, Heba F. Taha, Mohamed Riad, Amira A. Salem, Ola M. Elfarargy, Doaa Mandour

Publikováno v: Forum of Clinical Oncology, Vol 12, Iss 1, Pp 3-11 (2021)

Background Introducing neoadjuvant chemotherapy (NCT) in a breast cancer patient may be associated with changes in estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth hormone receptor 2 (HER2) status. Patients and methods In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e104603c49e9fb3f74bae457f37216db
https://doi.org/10.2478/fco-2019-0021

Zobrazit plný text záznamu

Prognostic Significance of Apoptosis Regulators in B-Cell Chronic Lymphocytic Leukemia

Autor: Khaled A. Elbana, Shereen El Shorbagy, Salah F. Elsayed, Ahmad Baraka, Lobna A. Abdelaziz, Ola M. Elfarargy, Rasha Haggag

Publikováno v: Journal of Cancer Therapy. :360-385

Background: High levels of MCL-1 and BCL-2 proteins have been found in Chronic Lymphocytic Leukemia (CLL), and inversely correlated with response to treatment. BCL-2/Bax ratio is the main director of apoptosis in CLL. The study aimed to clarify the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f97d86c1489031491b5e587f8062f330
https://doi.org/10.4236/jct.2017.84032

Zobrazit plný text záznamu

Peripheral and Tissue Lymphocytes as Predictors of Pathological Response in Locally Advanced Rectal Cancer Post Neoadjuvant Chemoradiotherapy

Autor: Amina M. Elnaggar, Reham A. Salem, Abeer M. Abdelbary, Loay M. Gertallah, Ola M. Elfarargy, Ola A. Harb, Hassan Ashour, Shereen El Shorbagy

Publikováno v: Journal of Cancer Therapy. :250-267

Background: Tailoring therapy is the target in the management of any cancer; if factors which can predict response to treatment are identified, we can individualize treatment. Locally advanced rectal cancer studies reported that tumor microenvironmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbcf8b63fda17022a4ff14eb25839564
https://doi.org/10.4236/jct.2017.83021

Zobrazit plný text záznamu

The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette–Guerin

Autor: Abdelmonem Awad Hegazy, Ahmed El-atar, Ola M. Elfarargy, Raafat Hegazy, Neveen A. Salem, Emad A. Salem, Amr Fawzy, Mostafa Kamel, Ahmed Sakr, Nashwa Nawar, Ashraf Shahin

Publikováno v: Arab Journal of Urology

Objective To investigate whether the immunohistochemical expression of p53, p63 and her2/neu is correlated with the prognosis of tumour recurrence and progression in patients with non-muscle invasive (NMI) bladder cancer. Patients and methods In all,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a43b262970ba8ca5bf86fb7bd2d57f
https://doi.org/10.1016/j.aju.2015.05.001

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání